Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation
- PMID: 12746453
- DOI: 10.1074/jbc.M303969200
Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation
Erratum in
- J Biol Chem. 2004 Jul 16;279(29):30914
Abstract
Cyclin D1 is a proto-oncogene that functions by inactivation of the retinoblastoma tumor suppressor protein, RB. A common polymorphism in the cyclin D1 gene is associated with the production of an alternate transcript of cyclin D1, termed cyclin D1b. Both the polymorphism and the variant transcript are associated with increased risk for multiple cancers and the severity of a given cancer; however, the underlying activities of cyclin D1b have not been elucidated relative to the canonical cyclin D1a. Because cyclin D1b does not possess the threonine 286 phosphorylation site required for nuclear export and regulated degradation, it has been hypothesized to encode a stable nuclear protein that would constitutively inactivate the RB pathway. Surprisingly, we find that cyclin D1b protein does not inappropriately accumulate in cells and exhibits stability comparable to cyclin D1a. As expected, the cyclin D1b protein was constitutively localized in the nucleus, whereas cyclin D1a was exported to the cytoplasm in S-phase. Despite enhanced nuclear localization, we find that cyclin D1b is a poor catalyst of RB phosphorylation/inactivation. However, cyclin D1b potently induced cellular transformation in contrast to cyclin D1a. In summary, we demonstrate that cyclin D1b specifically disrupts contact inhibition in a manner distinct from cyclin D1a. These data reveal novel roles for d-type cyclins in tumorigenesis.
Similar articles
-
Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.Mol Carcinog. 2009 Oct;48(10):953-64. doi: 10.1002/mc.20547. Mol Carcinog. 2009. PMID: 19415719
-
An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.Cancer Res. 2003 Nov 1;63(21):7056-61. Cancer Res. 2003. PMID: 14612495
-
Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.Circ Res. 2003 Jan 10;92(1):e12-9. doi: 10.1161/01.res.0000049105.15329.1c. Circ Res. 2003. PMID: 12522130
-
Cyclin D1: polymorphism, aberrant splicing and cancer risk.Oncogene. 2006 Mar 13;25(11):1620-8. doi: 10.1038/sj.onc.1209371. Oncogene. 2006. PMID: 16550162 Review.
-
Location, location, location: the role of cyclin D1 nuclear localization in cancer.J Cell Biochem. 2005 Dec 1;96(5):906-13. doi: 10.1002/jcb.20613. J Cell Biochem. 2005. PMID: 16163738 Review.
Cited by
-
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2190-5. doi: 10.1073/pnas.0506281103. Epub 2006 Feb 6. Proc Natl Acad Sci U S A. 2006. PMID: 16461912 Free PMC article.
-
Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.Mol Cell. 2006 Nov 3;24(3):355-66. doi: 10.1016/j.molcel.2006.09.007. Mol Cell. 2006. PMID: 17081987 Free PMC article.
-
Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.Oncogene. 2006 Feb 16;25(7):998-1007. doi: 10.1038/sj.onc.1209147. Oncogene. 2006. PMID: 16247460 Free PMC article.
-
Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium.Mol Carcinog. 2009 Sep;48(9):853-61. doi: 10.1002/mc.20531. Mol Carcinog. 2009. PMID: 19263437 Free PMC article.
-
The role of alternative pre-mRNA splicing in cancer progression.Cancer Cell Int. 2023 Oct 24;23(1):249. doi: 10.1186/s12935-023-03094-3. Cancer Cell Int. 2023. PMID: 37875914 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
